Skip to main content

RHUMBLINE ADVISERS

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1115418 BOSTON, MA

Position in KPTI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$229,272
+$215,010 QoQ
Shares Held
23,467
+2043.1% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 96 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 17% Shared 0% None 83%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. KPTI ranks #230 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KPTI

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $229,272 23,467
2024-06-30 $14,262 16,431
2024-03-31 $217,482 144,028
2023-12-31 $119,462 138,107
2023-09-30 $185,130 138,157
2023-06-30 $240,907 134,585
2023-03-31 $405,691 104,291
2022-12-31 $335,716 98,740
2022-09-30 $544,591 99,742
2022-06-30 $412,349 91,430
2022-03-31 $583,136 79,123
2021-12-31 $608,985 94,710
2021-09-30 $559,831 96,191
2021-06-30 $1,297,089 125,687
2021-03-31 $1,272,152 120,927
2020-12-31 $1,930,495 124,709
2020-09-30 $1,776,936 121,708
2020-06-30 $2,658,342 140,356
2020-03-31 $2,425,781 126,277